Press releaseGlobe Newswire
Aprea Therapeutics
APRE · NASDAQ
$0.5612−$0.0231 (−3.95%)TodayMarket closed ·
Prev close $0.5843
Latest news
- Press releaseGlobe Newswire
Aprea Therapeutics to Present Updated Interim Phase 1 Data on WEE1 Inhibitor APR-1051 in an Oral Presentation at 38th EORTC-NCI-AACR Symposium
- Press releaseGlobe Newswire
Aprea Therapeutics Announces Expansion of Intellectual Property Portfolio for Precision Oncology Programs
- News
12 Health Care Stocks Moving In Thursday's Intraday Session
- News
12 Health Care Stocks Moving In Monday's Intraday Session
- Press releaseGlobe Newswire
Aprea Therapeutics Announces Second Quarter 2026 Financial Results
- Press releasePRNewswire
Lipocine Appoints Michael J. Grissinger to Board of Directors
- Press releaseGlobe Newswire
Aprea Therapeutics Provides ACESOT-1051 Program Update for WEE1 Inhibitor APR-1051: Accelerating and Expanding Enrollment. Clinical Data Presentation Planned for Q4 2026
- Press releaseGlobe Newswire
Next-Generation DNA Repair Therapies Open New Frontiers in Oncology
- Press releaseGlobe Newswire
Aprea Therapeutics Presents Updated Phase 1 Data on WEE1 Inhibitor APR-1051 at ASCO 2026, Demonstrating Early Monotherapy Activity and Manageable Tolerability in Advanced Solid Tumors
- News
Earnings Scheduled For May 13, 2026
- Press releaseGlobe Newswire
Aprea Therapeutics Reports First Quarter 2026 Financial Results and Provides a Corporate Update
- Press releaseBusiness Wire
CatalYm Appoints Christian S. Schade as Chairman of the Board of Directors
- Press releaseGlobe Newswire
Aprea Therapeutics to Provide Clinical Update on ACESOT-1051 Phase 1 Trial Evaluating WEE1 Inhibitor, APR-1051, at ASCO 2026 Annual Meeting
- Press releaseBusiness Wire
Frazier Life Sciences Appoints Christian Schade as Senior Advisor
- News
12 Health Care Stocks Moving In Monday's Pre-Market Session
- News
12 Health Care Stocks Moving In Friday's Pre-Market Session
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- News
12 Health Care Stocks Moving In Wednesday's Intraday Session
- Press releaseGlobe Newswire
Aprea Therapeutics to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference
- Press releaseGlobe Newswire
Aprea Therapeutics to Present at H.C. Wainwright Global Investment Conference
- News
12 Health Care Stocks Moving In Wednesday's After-Market Session
- Press releaseBusiness Wire
Adicet Bio Reports First Quarter 2025 Financial Results and Provides Business Updates
- Press releaseBusiness Wire
Adicet Bio Appoints Michael Grissinger to the Board of Directors
- News
12 Health Care Stocks Moving In Monday's Pre-Market Session
- Press releaseBusiness Wire
Halda Therapeutics Appoints Veteran Biopharma Leader, Christian Schade, as President and Chief Executive Officer
- Press releasePRNewswire
Alltrna Announces Updates to Its Board of Directors
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.